Moore K - Search Results

1

Elevated plasma concentrations of atrial and brain natriuretic peptide in type 1 diabetic subjects.

McKenna K, Smith D, Sherlock M, Moore K, O'Brien E, Tormey W, Thompson CJ. McKenna K, et al. Among authors: moore k. Ir J Med Sci. 2005 Jul-Sep;174(3):53-7. doi: 10.1007/BF03169149. Ir J Med Sci. 2005. PMID: 16285340

2

The albuminuric action of atrial natriuretic peptide is not modified by ACE-inhibition with perindopril in Type 2 diabetes.

Moore KB, McKenna K, Tormey WP, McDonald D, Thompson CJ. Moore KB, et al. Diabet Med. 2003 Sep;20(9):713-6. doi: 10.1046/j.1464-5491.2003.00997.x. Diabet Med. 2003. PMID: 12925049 Clinical Trial.

3

Lipid lowering targets are easier to attain than those for treatment of hypertension in type 2 diabetes.

Sherlock M, Mylotte D, Mac Mahon J, Moore KB, Thompson CJ. Sherlock M, et al. Among authors: moore kb. Ir J Med Sci. 2006 Oct-Dec;175(4):36-41. doi: 10.1007/BF03167965. Ir J Med Sci. 2006. PMID: 17312827

4

Atrial natriuretic peptide increases urinary albumin excretion in people with normoalbuminuric type-2 diabetes.

Moore KB, McKenna K, Osman M, Tormey WP, McDonald D, Thompson CJ. Moore KB, et al. Ir J Med Sci. 2007 Jul-Sep;176(2):67-73. doi: 10.1007/s11845-007-0030-1. Epub 2007 May 3. Ir J Med Sci. 2007. PMID: 17476567 Clinical Trial.

5

Enhanced albuminuric response to atrial natriuretic peptide in normoalbuminuric patients with Type 1 diabetes mellitus--a pilot study.

McKenna K, Smith D, Moore K, Glen A, Kesson CM, Thompson CJ. McKenna K, et al. Among authors: moore k. Diabet Med. 2000 Jun;17(6):463-8. doi: 10.1046/j.1464-5491.2000.00303.x. Diabet Med. 2000. PMID: 10975216 Clinical Trial.

6

Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in Type 1 diabetes mellitus.

McKenna K, Smith D, Moore K, Glen A, Tormey W, Thompson CJ. McKenna K, et al. Among authors: moore k. Diabet Med. 2001 Dec;18(12):973-8. doi: 10.1046/j.0742-3071.2001.00569.x. Diabet Med. 2001. PMID: 11903396 Clinical Trial.

7

Adherence to physical activity recommendations and barriers to physical activity participation among adults with type 1 diabetes.

Finn M, Sherlock M, Feehan S, Guinan EM, Moore KB. Finn M, et al. Ir J Med Sci. 2022 Aug;191(4):1639-1646. doi: 10.1007/s11845-021-02741-w. Epub 2021 Aug 24. Ir J Med Sci. 2022. PMID: 34427840 Free PMC article.

8

Baroregulation of vasopressin release in adipsic diabetes insipidus.

Smith D, McKenna K, Moore K, Tormey W, Finucane J, Phillips J, Baylis P, Thompson CJ. Smith D, et al. Among authors: moore k. J Clin Endocrinol Metab. 2002 Oct;87(10):4564-8. doi: 10.1210/jc.2002-020090. J Clin Endocrinol Metab. 2002. PMID: 12364435

9

Diabetes and extreme altitude mountaineering.

Moore K, Thompson C, Hayes R. Moore K, et al. Br J Sports Med. 2001 Apr;35(2):83. doi: 10.1136/bjsm.35.2.83. Br J Sports Med. 2001. PMID: 11273966 Free PMC article. No abstract available.

10

Extreme altitude mountaineering and Type 1 diabetes; the Diabetes Federation of Ireland Kilimanjaro Expedition.

Moore K, Vizzard N, Coleman C, McMahon J, Hayes R, Thompson CJ. Moore K, et al. Diabet Med. 2001 Sep;18(9):749-55. doi: 10.1046/j.0742-3071.2001.00568.x. Diabet Med. 2001. PMID: 11606174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,854 results

Search Page

Filters